epoetin beta · Medicine question

In which premature infants is NeoRecormon (epoetin beta) indicated for prevention of anaemia?

Name: In which premature infants is NeoRecormon (epoetin beta) indicated for prevention of anaemia?
Published: 2026-11-08T13:47:16.705Z

iatroX medicinesPublished 8 November 2026

The answer

Answer

NeoRecormon (epoetin beta) is indicated for prevention of anaemia of prematurity in infants with a birth weight of 750–1500 g and a gestational age of less than 34 weeks.

Sources for this answer

Neorecormon Solution for Injection in Pre-Filled SyringeRoche Products Limited · emc · SmPC §4.1 Therapeutic Indications · Version 31Document updated 16 September 2026

Sources checked 8 November 2026

loading page…

Answer

Sources for this answer

Answer

Sources for this answer

More questions about epoetin beta